![Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer]()
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerCunningham, David; Humblet, Yves; Siena, Salvatore; Khayat, David; Bleiberg, Harry; Santoro, Armando; Bets, Danny; Mueser, Matthias; Harstrick, Andreas; Verslype, Chris; Chau, Ian; Van Cutsem, Eric · New England Journal of Medicine · 2004